Supernus Pharmaceuticals, Inc. (SUPN)
41.21
-0.02
(-0.05%)
USD |
NASDAQ |
Oct 21, 16:00
41.21
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Net Income (Annual) : -38.55M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -38.55M |
| December 31, 2024 | 73.86M |
| December 31, 2023 | 1.316M |
| December 31, 2022 | 60.71M |
| December 31, 2021 | 53.42M |
| December 31, 2020 | 126.95M |
| December 31, 2019 | 113.06M |
| December 31, 2018 | 110.99M |
| December 31, 2017 | 57.28M |
| December 31, 2016 | 91.22M |
| Date | Value |
|---|---|
| December 31, 2015 | 13.94M |
| December 31, 2014 | 19.87M |
| December 31, 2013 | -92.27M |
| December 31, 2012 | -46.28M |
| December 31, 2011 | -23.22M |
| December 31, 2010 | -39.08M |
| December 31, 2009 | 4.138M |
| December 31, 2008 | -33.48M |
| December 31, 2007 | -17.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Indivior Pharmaceuticals, Inc. | 210.00M |
| Prestige Consumer Healthcare, Inc. | 190.30M |
| Pfizer Inc. | 7.787B |
| Amphastar Pharmaceuticals, Inc. | 98.09M |
| Bristol Myers Squibb Co. | 7.056B |